133 Publications (Page 3 of 6)
2012
Single-Cell Network Profiling (SCNP)-Based Classifier to Predict Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia (AML): Validation in Two Independent Sample Sets From ECOG and SWOG Trials
Cesano, Alessandra⋅Willman, Cheryl L⋅Kopecky, Kenneth J⋅Gayko, Urte⋅Putta, Santosh⋅Louie, Brent⋅Westfall, Matt⋅Purvis, Norman⋅Spellmeyer, David⋅Marimpietri, Carol⋅Hackett, James⋅Shi, Jing⋅Paietta, Elisabeth⋅Tallman, Martin S⋅Cripe, Larry D⋅Atwater, Susan K⋅Appelbaum, Frederick R and Radich, Jerald P
Blood, vol. 120, (no. 21), pp. 2489, 2012-11-16. | Journal Article
2011
A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia.
Lancet, Jeffrey⋅Ravandi, F⋅Ricklis, R M⋅Cripe, L D⋅Kantarjian, H M⋅Giles, Francis J⋅List, Alan F⋅Chen, T⋅Allen, R S⋅Fox, J A⋅Michelson, G C and Karp, J E
Leukemia, vol. 25, (no. 12), pp. 1808-14, 2011/Dec. | Journal Article
 
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse.
Levis, Mark⋅Levis, Mark J⋅Ravandi Kashani, Farhad⋅Ravandi, Farhad⋅Wang, Eunice S⋅Wang, Eunice S⋅Baer, Maria R⋅Baer, Maria R⋅Perl, Alexander⋅Perl, Alexander⋅Coutre, Steven⋅Coutré, Steven E⋅Erba, Harry⋅Erba, Harry⋅Stuart, Robert K⋅Stuart, Robert K⋅Baccarani, Michele⋅Baccarani, Michele⋅Cripe, Larry D⋅Cripe, Larry D⋅Tallman, Martin S⋅Tallman, Martin S⋅Meloni, Giovanna⋅Meloni, Giovanna⋅Godley, Lucy A⋅Godley, Lucy A⋅Langston, Amelia A⋅Langston, Amelia A⋅Amadori, Sergio⋅Amadori, Sergio⋅Lewis, Ian D⋅Lewis, Ian D⋅Nagler, Arnon⋅Nagler, Arnon⋅Stone, Richard⋅Stone, Richard⋅Yee, Karen⋅Yee, Karen⋅Advani, Anjali⋅Advani, Anjali⋅Douer, Dan⋅Douer, Dan⋅Wiktor-Jedrzejczak, W⋅Wiktor-Jedrzejczak, W⋅Juliusson, Gunnar⋅Juliusson, Gunnar⋅Litzow, Mark R⋅Litzow, Mark R⋅Petersdorf, Stephen⋅Petersdorf, Stephen⋅Sanz, Miguel⋅Sanz, Miguel⋅Kantarjian, Hagop M⋅Kantarjian, Hagop⋅Sato, Takashi⋅Sato, Takashi⋅Tremmel, Lothar⋅Tremmel, Lothar⋅Bensen-Kennedy, Debra M⋅Bensen-Kennedy, Debra M⋅Small, Donald⋅Small, Donald⋅Smith, B D and Smith, B Douglas
Blood, vol. 117, (no. 12), pp. 3294-301, 2011/Mar/24. | Journal Article
 
Single Cell Network Profiling (SCNP) Functionally Characterizes FLT3 Pathway Deregulation in Non-M3 Acute Myeloid Leukemia (AML) and Provides Prognostic Value Independent From Mutational Status
Cesano, Alessandra⋅Putta, Santosh⋅Mathi, Kavita⋅Rosen, David B⋅Gayko, Urte⋅Hawtin, Rachael E⋅Cripe, Larry D⋅Sun, Zhuoxin⋅Tallman, Martin S and Paietta, Elisabeth
Blood, vol. 118, (no. 21), pp. 2512, 2011-11-18. | Journal Article
 
The Impact of Obesity on the Presentation & Outcome of Adult Acute Myeloid Leukemia (AML) - ECOG Studies E1900 & E3999
Foran, James M⋅Sun, Zhuoxin⋅Fernandez, Hugo F⋅Cripe, Larry D⋅Ketterling, Rhett P⋅Racevskis, Janis⋅Luger, Selina M⋅Paietta, Elisabeth⋅Lazarus, Hillard M⋅Litzow, Mark R and Tallman, Martin S
Blood, vol. 118, (no. 21), pp. 2568, 2011-11-18. | Journal Article
 
Thrice weekly azacitidine does not improve hematological responses in lower-risk myelodysplastic syndromes: a study of the Hoosier Oncology Group.
Sayar, Hamid⋅Chan, Rebecca⋅Orschell, Christie M⋅Chan, Edward M⋅Yu, Zhangsheng⋅Hood, Daniel⋅Plett, Artur⋅Yang, Zhenyun⋅Hui, Chua L⋅Nabinger, Sarah C⋅Kohlbacher, Kristopher J⋅West, Evan S⋅Walter, Amanda⋅Sampson, Carol⋅Wu, Jingwei and Cripe, Larry D
Leukemia research, vol. 35, (no. 8), pp. 1108-10, 2011/Aug. | Journal Article
 
Trustworthiness.
Cripe, Larry D
(pp. 3483-3486). September 1, 2011
 
Trustworthiness.
Cripe, Larry D
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 29, (no. 25), pp. 3483-6, 2011/Sep/1. | Journal Article
2010
A Pathway-focused GSEA Platform In AML That Interrogates Interaction of Flt3ITD and tMLL with Their Epigenetic Targets (p16INK4a, DAPK1, and RUNX3), While Accurately Reporting Broad-based AML Prognosis and Targeting-agent Sensitivity
Baghdadi, Tareq Al⋅Goswami, Chirayu⋅Sayar, Hamid⋅Sargent, Katie J⋅Cripe, Larry⋅Li, Lang⋅Shanmugam, Rajasubramaniam and Boswell, H. Scott
Blood, vol. 116, (no. 21), pp. 1660, 2010-11-19. | Journal Article
 
Characterization of FLT3 Pathway Deregulation by Single Cell Network Profiling (SCNP) Stratifies AML Patients Beyond Molecular Profiling
Rosen, David B⋅Putta, Santosh⋅Gayko, Urte⋅Cesano, Alessandra⋅Cripe, Larry⋅Sun, Zhuoxin⋅Litzow, Mark R⋅Uno, Hajime⋅Tallman, Martin S and Paietta, Elisabeth
Blood, vol. 116, (no. 21), pp. 2739, 2010-11-19. | Journal Article
 
Cyclic Administration of Combination of Sorafenib and Vorinostat In Poor-Risk AML: A Pharmacodynamically-Oriented Extended Phase I Trial
Sayar, Hamid⋅Cripe, Larry⋅Cangany, Mary⋅Weisenbach, Jill⋅Sargent, Katie J⋅Goswami, Chirayu⋅Li, Lang⋅Wilson-Weekes, Annique⋅Shanmugam, Rajasubramaniam and Boswell, H. Scott
Blood, vol. 116, (no. 21), pp. 3272, 2010-11-19. | Journal Article
 
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group.
Litzow, Mark R⋅Othus, Megan⋅Cripe, Larry D⋅Gore, Steven D⋅Lazarus, Hillard M⋅Lee, Sandra J⋅Bennett, John M⋅Paietta, Elisabeth M⋅Dewald, Gordon W⋅Rowe, Jacob M and Tallman, Martin S
British journal of haematology, vol. 148, (no. 2), pp. 217-25, 2010/Jan. | Journal Article
 
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Friedberg, Jonathan W⋅Sharman, Jeff⋅Sweetenham, John⋅Johnston, Patrick L⋅Vose, Julie M⋅La Casce, Ann S⋅Lacasce, Ann⋅Schaefer-Cutillo, Julia⋅De Vos, Sven⋅Sinha, Rajni⋅Leonard, John P⋅Cripe, Larry D⋅Gregory, Stephanie A⋅Sterba, Michael P⋅Lowe, Ann M⋅Levy, Ronald and Shipp, Margaret A
Blood, vol. 115, (no. 13), pp. 2578-85, 2010/Apr/1. | Journal Article
 
Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903.
Mesa, Ruben A⋅Yao, Xiaopan⋅Cripe, Larry D⋅Li, Chin Y⋅Litzow, Mark⋅Paietta, Elisabeth M⋅Rowe, Jacob M⋅Tefferi, Ayalew and Tallman, Martin S
Blood, vol. 116, (no. 22), pp. 4436-8, 2010/Nov/25. | Journal Article
 
Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.
Nelson, Robert P⋅Yu, Menggang⋅Schwartz, Jennifer⋅Robertson, Michael J⋅Hromas, Robert A⋅Fausel, C A⋅Vance, Gail H⋅Dlouhy, Stephen R⋅Baute, J A⋅Cox, E A⋅Wood, L L⋅Srivastava, Shivani⋅Robertson, Kent⋅Haut, P R⋅Farag, Sherif S⋅Abonour, Rafat⋅Cornetta, Kenneth G and Cripe, Larry D
Bone marrow transplantation, vol. 45, (no. 8), pp. 1300-8, 2010/Aug. | Journal Article
 
Monosomal Karyotype (MK) In Older Patients with Acute Myeloid Leukemia (AML) on Eastern Cooperative Oncology Group (ECOG) Therapeutic Trials: Poor Prognostic Impact of MK, but Not of Monosomy 7
Strickland, Stephen A⋅Strickland, Stephen A⋅Sun, Zhuoxin⋅Sun, Zhuoxin⋅Ketterling, Rhett P⋅Ketterling, Rhett P⋅Cherry, Athena M⋅Cherry, Athena M⋅Cripe, Larry D⋅Cripe, Larry D⋅Dewald, Gordon⋅Dewald, Gordon⋅Higgins, Rodney R⋅Higgins, Rodney R⋅Lazarus, Hillard M⋅Lazarus, Hillard M⋅Litzow, Mark R⋅Litzow, Mark R⋅Luger, Selina M⋅Luger, Selina M⋅Paietta, Elisabeth⋅Paietta, Elisabeth⋅Rowe, Jacob M⋅Rowe, Jacob M⋅Uno, Hajime⋅Uno, Hajime⋅Vance, Gail H⋅Vance, Gail H⋅Tallman, Martin S and Tallman, Martin S
Blood, vol. 116, (no. 21), pp. 579, 2010-11-19. | Journal Article
 
Single-Cell Network Profiliing (SCNP) Signatures Independently Predict Response to Induction Therapy In Older Patients with Acute Myeloid Leukemia (AML)
Cesano, Alessandra⋅Putta, Santosh⋅Gayko, Urte⋅Hackett, James⋅Rosen, David B⋅Cripe, Larry⋅Sun, Zhuoxin⋅Uno, Hajime⋅Litzow, Mark R⋅Tallman, Martin S and Paietta, Elisabeth
Blood, vol. 116, (no. 21), pp. 2695, 2010-11-19. | Journal Article
 
Specimen Source (BM or PB) Does Not Affect Proteomic Signaling In Patients with AML and Circulating Blasts
Cesano, Alessandra⋅Rosen, David B⋅Putta, Santosh⋅Gayko, Urte⋅Cripe, Larry⋅Sun, Zhuoxin⋅Uno, Hajime⋅Litzow, Mark R⋅Tallman, Martin S and Paietta, Elisabeth
Blood, vol. 116, (no. 21), pp. 2693, 2010-11-19. | Journal Article
 
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999.
Cripe, Larry D⋅Cripe, Larry D⋅Uno, Hajime⋅Uno, Hajime⋅Paietta, Elisabeth M⋅Paietta, Elisabeth M⋅Litzow, Mark R⋅Litzow, Mark R⋅Ketterling, Rhett P⋅Ketterling, Rhett P⋅Bennett, John M⋅Bennett, John M⋅Rowe, Jacob M⋅Rowe, Jacob M⋅Lazarus, Hillard M⋅Lazarus, Hillard M⋅Luger, Selina M⋅Luger, Selina⋅Tallman, Martin S and Tallman, Martin S
Blood, vol. 116, (no. 20), pp. 4077-85, 2010/Nov/18. | Journal Article
2009
A Phase 2 Dose Regimen Optimization Study of Three Schedules of Voreloxin as Single Agent Therapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia
Ravandi, Farhad⋅Kantarjian, Hagop M⋅Cripe, Larry D⋅Maris, Michael⋅Cooper, Maureen⋅Dakhil, Shaker R⋅Stone, Richard M⋅Turturro, Francesco⋅Chen, Tianling⋅Mahadocon, Kristi⋅Fox, Judith⋅Berman, Craig⋅Michelson, Glenn C and Stuart, Robert K
Blood, vol. 114, (no. 22), pp. 1037, 2009-11-20. | Journal Article
 
A piece of my mind. Giving up.
Cripe, Larry D
JAMA : the journal of the American Medical Association, vol. 301, (no. 17), pp. 1747-8, 2009/May/6. | Journal Article
 
Dying pretty.
Cripe, Larry D
Journal of palliative medicine, vol. 12, (no. 9), pp. 839-40, 2009/Sep. | Journal Article
 
Foreword. The discovered story: the evolution of truth in cancer narratives
Cripe, Larry D
Literature and medicine, vol. 28, (no. 2), pp. vi, 2009-Fall. | Journal Article
 
Giving Up
Cripe, Larry D
JAMA, vol. 301, (no. 17), May 6, 2009. | Journal Article
 
Phase 1b/2 Pharmacokinetic/Pharmacodynamic (PK/PD) Study of Combination Voreloxin and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia Patients
Lancet, Jeffrey E⋅Roboz, Gail J⋅Cripe, Larry D⋅Maris, Michael⋅List, Alan F⋅Fox, Judith⋅Michelson, Glenn C and Karp, Judith
Blood, vol. 114, (no. 22), pp. 635, 2009-11-20. | Journal Article